Vasculitis in 2011: The renaissance of granulomatous inflammation in AAV

Nature Reviews Rheumatology

Volumn 8, Issue 2, 2012, Pages 74-76

  Gadola, Stephan D ^a   Gross, Wolfgang L ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN TM4SF2; PROTEIN TMEM9B; RITUXIMAB; UNCLASSIFIED DRUG;

ANCA ASSOCIATED VASCULITIS; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTIFICIAL NEURAL NETWORK; B LYMPHOCYTE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GRANULOMATOUS INFLAMMATION; HUMAN; INNATE IMMUNITY; LUNG TUMOR; LYMPHOCYTE FUNCTION; MICROSCOPIC POLYANGIITIS; ORBIT TUMOR; PRIORITY JOURNAL; REVIEW; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HUMANS; IMMUNOLOGIC FACTORS; NEURAL NETWORKS (COMPUTER); TERMINOLOGY AS TOPIC; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 84856619262     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.218     Document Type: Review

References (10)

1. Falk, R. J. et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 63, 863-864 (2011).
2. Linder, R. et al. Differentiation between Wegener's granulomatosis and microscopic polyangiitis by an artificial neural network and by traditional methods. J. Rheumatol 38, 1039-1047 (2011).
3. Schmitt, W. H., Linder, R., Reinhold-Keller, E. & Gross, W. L. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network. Arthritis Rheum. 44, 1887-1896 (2001). (Pubitemid 32758237)
4. Fujimoto, S. et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology (Oxford) 50, 1916-1920 (2011).
5. Arning, L. et al. Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis? Ann. Rheum. Dis. 70, 707-708 (2010).
6. Holle, J. U. et al. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann. Rheum. Dis. 69, 1934-1939 (2010).
7. Holle, J. U. et al. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ ard.2011.153601
8. Holden, N. J. et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann. Rheum. Dis. 70, 2229-2233 (2010).
9. Thurner, L. et al. Wegener's granuloma harbour B lymphocytes with specificities against a proinflammatory transmembrane protein and a tetraspanin. J. Autoimmun. 36, 87-90 (2011).
10. Laudien, N. et al. Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener's granulomatosis. Mucosal Immunol. 4, 564-573 (2011).